Quinones as disease therapies

Details Quinones as disease therapies Quinones as disease therapies

2007-08-07

2007-08-07

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S455000, C530S300000, C549S389000, C549S458000, C552S290000, C552S291000, C552S292000, C552S293000

Reexamination Certificate

active

10909978

ABSTRACT:
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.

REFERENCES:
patent: 4035174 (1977-07-01), Grier et al.
patent: 4092432 (1978-05-01), Bjorklund et al.
patent: 4153567 (1979-05-01), Kluger et al.
patent: 4273706 (1981-06-01), Chapman et al.
patent: 4491651 (1985-01-01), Naiman
patent: 4537601 (1985-08-01), Naiman
patent: 4577636 (1986-03-01), Spears
patent: 4590288 (1986-05-01), Klemann
patent: 4642344 (1987-02-01), Hajek et al.
patent: 4698446 (1987-10-01), Lai et al.
patent: 4767611 (1988-08-01), Gordon
patent: 4849207 (1989-07-01), Sakata et al.
patent: 4898870 (1990-02-01), Narutomi et al.
patent: 4935449 (1990-06-01), Bey et al.
patent: 4959356 (1990-09-01), Miura et al.
patent: 4963565 (1990-10-01), Gangadharam
patent: 4992257 (1991-02-01), Bonnett et al.
patent: 4996312 (1991-02-01), Sakata et al.
patent: 5007437 (1991-04-01), Sterzer
patent: 5021409 (1991-06-01), Murrer et al.
patent: 5021571 (1991-06-01), Mease et al.
patent: 5080998 (1992-01-01), Irving et al.
patent: 5120843 (1992-06-01), McCall et al.
patent: 5210239 (1993-05-01), Abe et al.
patent: 5217964 (1993-06-01), Edwards et al.
patent: 5284647 (1994-02-01), Niedballa et al.
patent: 5344435 (1994-09-01), Turner et al.
patent: 5354782 (1994-10-01), Edwards et al.
patent: 5354858 (1994-10-01), Morgan et al.
patent: 5374658 (1994-12-01), Lau
patent: 5385942 (1995-01-01), Abe et al.
patent: 5401443 (1995-03-01), Nagano et al.
patent: 5413719 (1995-05-01), Sivakumar et al.
patent: 5424305 (1995-06-01), Skalkos et al.
patent: 5434145 (1995-07-01), Edwards et al.
patent: 5498522 (1996-03-01), Porter
patent: 5512559 (1996-04-01), Skalkos et al.
patent: 5516807 (1996-05-01), Hupe et al.
patent: 5541230 (1996-07-01), Basu et al.
patent: 5563262 (1996-10-01), Morgan et al.
patent: 5587394 (1996-12-01), Morgan et al.
patent: H1633 (1997-02-01), Hiebert et al.
patent: 5599686 (1997-02-01), DeFeo-Jones et al.
patent: 5606053 (1997-02-01), Prashad et al.
patent: 5607574 (1997-03-01), Hart
patent: 5608061 (1997-03-01), Ciszewski et al.
patent: 5612478 (1997-03-01), Xu et al.
patent: 5627215 (1997-05-01), Frei et al.
patent: 5641773 (1997-06-01), Pardee et al.
patent: 5646188 (1997-07-01), Gilad et al.
patent: 5654287 (1997-08-01), Prakash et al.
patent: 5672202 (1997-09-01), Stirling et al.
patent: 5674900 (1997-10-01), Ubillas et al.
patent: 5677349 (1997-10-01), Gilad et al.
patent: 5677350 (1997-10-01), Frydman
patent: 5681837 (1997-10-01), Bergeron
patent: 5693632 (1997-12-01), Morgan et al.
patent: 5707532 (1998-01-01), Guerro et al.
patent: 5744453 (1998-04-01), Mintz et al.
patent: 5763388 (1998-06-01), Lightsey et al.
patent: 5763625 (1998-06-01), Boothman et al.
patent: 5776458 (1998-07-01), Angelucci et al.
patent: 5780514 (1998-07-01), Gutteridge et al.
patent: 5783598 (1998-07-01), Boyd et al.
patent: 5824700 (1998-10-01), Frydman et al.
patent: 5849259 (1998-12-01), Hilger et al.
patent: 5866679 (1999-02-01), DeFeo-Jones et al.
patent: 5869522 (1999-02-01), Boyd et al.
patent: 5877165 (1999-03-01), Miura et al.
patent: 5880161 (1999-03-01), Basu et al.
patent: 5883270 (1999-03-01), Frydman et al.
patent: 5886173 (1999-03-01), Hemmi et al.
patent: 5889061 (1999-03-01), Frydman et al.
patent: 5912241 (1999-06-01), Gottlieb et al.
patent: 5962533 (1999-10-01), Bergeron, Jr.
patent: 5969163 (1999-10-01), Frydman et al.
patent: 5977187 (1999-11-01), Frydman et al.
patent: 5985331 (1999-11-01), Gottlieb et al.
patent: 5998362 (1999-12-01), Feng et al.
patent: 6001573 (1999-12-01), Roelant
patent: 6025351 (2000-02-01), Morgan et al.
patent: 6066628 (2000-05-01), Stojiljkovic et al.
patent: 6083479 (2000-07-01), Platzek et al.
patent: 6100430 (2000-08-01), Yamamoto et al.
patent: 6130204 (2000-10-01), DeFeo-Jones et al.
patent: 6143864 (2000-11-01), DeFeo-Jones et al.
patent: 6174858 (2001-01-01), Brady et al.
patent: 6177561 (2001-01-01), Sinn et al.
patent: 6265540 (2001-07-01), Isaacs et al.
patent: 6482943 (2002-11-01), Blokhin et al.
patent: 6809176 (2004-10-01), Blokhin et al.
patent: 2002/0004031 (2002-01-01), Dinkelborg et al.
patent: 2002/0183512 (2002-12-01), Blokhin et al.
patent: 2003/0013677 (2003-01-01), Blokhin et al.
patent: 1 295 826 (1969-05-01), None
patent: 0 255 679 (1988-02-01), None
patent: 0 255 679 (1988-02-01), None
patent: 0 255 679 (1988-02-01), None
patent: 07-277964 (1995-10-01), None
patent: 05-032902 (1996-02-01), None
patent: 09-235280 (1997-09-01), None
patent: WO-94/07894 (1994-04-01), None
patent: WO 94/08578 (1994-04-01), None
patent: WO-95/18091 (1995-07-01), None
patent: WO-96/22962 (1996-08-01), None
patent: WO 96/33988 (1996-10-01), None
patent: WO-96/40096 (1996-12-01), None
patent: WO-97/02027 (1997-01-01), None
patent: WO 97/02030 (1997-01-01), None
patent: WO 97/08162 (1997-03-01), None
patent: WO-97/29199 (1997-08-01), None
patent: WO 97/30022 (1997-08-01), None
patent: WO 97/31611 (1997-09-01), None
patent: WO 97/31936 (1997-09-01), None
patent: WO 97/31936 (1997-09-01), None
patent: WO-98/17624 (1998-04-01), None
patent: WO 98/25884 (1998-06-01), None
patent: WO 98/25885 (1998-06-01), None
patent: WO-98/32729 (1998-07-01), None
patent: WO-98/33503 (1998-08-01), None
patent: WO-98/37057 (1998-08-01), None
patent: WO-98/52966 (1998-11-01), None
patent: WO-99/13920 (1999-03-01), None
patent: WO-99/16474 (1999-04-01), None
patent: WO-99/16757 (1999-04-01), None
patent: WO-99-62512 (1999-12-01), None
patent: WO-00/01419 (2000-01-01), None
patent: WO-00/05235 (2000-02-01), None
patent: WO-00/17205 (2000-03-01), None
patent: WO-00/18439 (2000-04-01), None
patent: WO-00/66175 (2000-11-01), None
patent: WO-00/66175 (2000-11-01), None
patent: WO 00/66528 (2000-11-01), None
patent: WO 00/66528 (2000-11-01), None
patent: WO-00/66587 (2000-11-01), None
Cassis, R. et al. (Mar.-Apr. 1982). “Studies on Quinones. VIII(1). The Application of Michael Adducts from 2-Hydroxy-1,4-naphthoquinones for the Preparation of Dihydronaphthopyrandiones (2),”Journal of Heterocyclic Chemistry19:381-384.
European Search Report mailed on Sep. 14, 2005 for European Patent Application No. 05011989.0 filed on Apr. 27, 2000, 4 pages.
Guay, V. et al. (Jan.-Feb. 1986), “Synthesis of (±)-7- and 8-Hydroxydunnione,”Journal of Natural Products49(1):122-125.
Inoue, K. et al. (Jun. 1, 1982). “Structures of Unusually Prenylated Naphthoquinones ofStreptocarpus dunniiand its Cell Cultures,”Chemical and Pharmaceutical Bulletin30(6):2265-2268.
Akgun, N. et al. (1996). “Phototoxicity, Darktoxicity and Uptake Kinetics of Natural Hydrophilic and Hydrophobic Phorphyrins in Endothelial Cells,”Proc. SPIE-Int. Soc. Opt. Eng.2625:488-498.
Alfonso, I. et al. (1996). “Sequential Biocatalytic Resolution of (+)-trans-cyclohexane-1,2-diamine. Chemoenzymic Synthesis of an Optically Active Polyamine,”Chem. Commun.21:2471-2472.
Allolio, B. et al. (1989). “Treatment of Metastasizing Adrenal Carcinoma with Suramin,”Dtsch. Med. Wuschenschr114(10):381-384. (In German; first page of document has English abstract).
Bachrach, U. et al. (1971). “Inactivation of Myxoviruses by Oxidized Polyamines,”J. Gen. Virol.11:1-9.
Bachrach, U. et al. (Feb. 1972). “Effect of Oxidized Spermine and Other Aldehydes on the Infectivity of Vaccinia Virus,”Appl. Microbiol.23(2):232-235.
Bachrach, U. et al. (1971). “Antivirus Action of Acrolein, Glutaraldehyde and Oxidized Spermine,”J. Gen. Virol.13:415-422.
Basu, H.S. et al. (1990). “Effects of Variation in the Structure of Spermine on the Association with DNA and the Induction of DNA Conformational Changes,”Biochem. J.269:329-334.
Behe, M. et al. (Mar. 1981). “Effects of Methylation on a Synthetic Polynucleotide: the B-Z Transition in Poly(dG-m5dC)-Poly(dG-m5dC),”Proc. Natl. Acad. Sci. USA78(3):1619-1623.
Berchtold, C.M. et al. (1998), “Inhibition of Cell Growth in CaCO2 Cells by the Polyamine Analogue N.sup.1,

Affiliated with

Also associated with

Rating

Quinones as disease therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinones as disease therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinones as disease therapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3884599